We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > INOmax

News List

Mallinckrodt launches retrospective study for inhaled therapy in COVID-19 pharmatimes
November 12, 2020
Mallinckrodt has launched a retrospective chart review study which will collect real-world data on the use of INOmax (nitric oxide) gas for inhalation therapy in patients with respiratory complications associated with COVID-19.
Mallinckrodt's INOmax (Nitric Oxide) Gas, for Inhalation, Approved in Australia for Pulmonary Hypertension in Adults in Conjunction with Cardiovascular Surgery firstwordpharma
April 11, 2019
Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company……
Mallinckrodt's INOmax receives approval in Australia biospectrumasia
April 11, 2019
INOmax was previously approved for this same indication in neonates through adolescents up to age 17……